• Return to Headlines

Pacira Pharmaceu has the Highest Forward P/E Ratio in the Pharmaceuticals Industry (PCRX, ZTS, COLL, CTLT, LLY)

By Nick Russo

Below are the three companies in the Pharmaceuticals industry with the highest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among companies in the same industry. Generally, the lower the forward P/E, the more undervalued a company is believed to be.

Pacira Pharmaceu ranks highest with a a forward P/E ratio of 35.95. Zoetis Inc is next with a a forward P/E ratio of 35.35. Collegium Pharma ranks third highest with a a forward P/E ratio of 28.65.

Catalent Inc follows with a a forward P/E ratio of 25.17, and Eli Lilly & Co rounds out the top five with a a forward P/E ratio of 25.16.

SmarTrend is tracking the current trend status for Pacira Pharmaceu and will alert subscribers who have PCRX in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest forward p/e ratio pacira pharmaceu zoetis inc collegium pharma catalent inc eli lilly & co

Ticker(s): PCRX ZTS COLL CTLT LLY